Expanding the evidence base in transplantation: The complementary roles of randomized controlled trials and outcomes research

Steven K. Takemoto, Wolfgang Arns, Suphamai Bunnapradist, Louis P. Garrison, Lluis Guirado, Z. Kaló, Gabriel Oniscu, Gerhard Opelz, Maria Piera Scolari, Sergio Stefoni, Magdi Yaqoob, Daniel C. Brennan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery and collaboration necessary for the transplant procedure makes randomization and blinding difficult. Because essentially every recipient is included in a transplant registry, sampling bias is minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy of new drugs or medical interventions. This workgroup summary examines the suitability of outcomes research to complement results of randomized controlled trials and related issues: efficacy versus effectiveness, internal versus external validity, data types, limitations, and analysis methodologies. Many advances in outcomes research have been pioneered in transplantation. A case is made for regulatory and reimbursement authorities to use outcomes research when making efficacy, effectiveness, and coverage decisions in transplantation.

Original languageEnglish
Pages (from-to)18-25
Number of pages8
JournalTransplantation
Volume86
Issue number1
DOIs
Publication statusPublished - Jul 15 2008

Fingerprint

Randomized Controlled Trials
Transplantation
Outcome Assessment (Health Care)
Transplants
Selection Bias
Random Allocation
Registries
Pharmaceutical Preparations

Keywords

  • Immunosuppression
  • Outcomes research
  • Randomized controlled trial
  • Registry analysis
  • Transplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Expanding the evidence base in transplantation : The complementary roles of randomized controlled trials and outcomes research. / Takemoto, Steven K.; Arns, Wolfgang; Bunnapradist, Suphamai; Garrison, Louis P.; Guirado, Lluis; Kaló, Z.; Oniscu, Gabriel; Opelz, Gerhard; Scolari, Maria Piera; Stefoni, Sergio; Yaqoob, Magdi; Brennan, Daniel C.

In: Transplantation, Vol. 86, No. 1, 15.07.2008, p. 18-25.

Research output: Contribution to journalArticle

Takemoto, SK, Arns, W, Bunnapradist, S, Garrison, LP, Guirado, L, Kaló, Z, Oniscu, G, Opelz, G, Scolari, MP, Stefoni, S, Yaqoob, M & Brennan, DC 2008, 'Expanding the evidence base in transplantation: The complementary roles of randomized controlled trials and outcomes research', Transplantation, vol. 86, no. 1, pp. 18-25. https://doi.org/10.1097/TP.0b013e31817d4df5
Takemoto, Steven K. ; Arns, Wolfgang ; Bunnapradist, Suphamai ; Garrison, Louis P. ; Guirado, Lluis ; Kaló, Z. ; Oniscu, Gabriel ; Opelz, Gerhard ; Scolari, Maria Piera ; Stefoni, Sergio ; Yaqoob, Magdi ; Brennan, Daniel C. / Expanding the evidence base in transplantation : The complementary roles of randomized controlled trials and outcomes research. In: Transplantation. 2008 ; Vol. 86, No. 1. pp. 18-25.
@article{30d9b40ec14b4d5cbe9df128b456b3ce,
title = "Expanding the evidence base in transplantation: The complementary roles of randomized controlled trials and outcomes research",
abstract = "Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery and collaboration necessary for the transplant procedure makes randomization and blinding difficult. Because essentially every recipient is included in a transplant registry, sampling bias is minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy of new drugs or medical interventions. This workgroup summary examines the suitability of outcomes research to complement results of randomized controlled trials and related issues: efficacy versus effectiveness, internal versus external validity, data types, limitations, and analysis methodologies. Many advances in outcomes research have been pioneered in transplantation. A case is made for regulatory and reimbursement authorities to use outcomes research when making efficacy, effectiveness, and coverage decisions in transplantation.",
keywords = "Immunosuppression, Outcomes research, Randomized controlled trial, Registry analysis, Transplantation",
author = "Takemoto, {Steven K.} and Wolfgang Arns and Suphamai Bunnapradist and Garrison, {Louis P.} and Lluis Guirado and Z. Kal{\'o} and Gabriel Oniscu and Gerhard Opelz and Scolari, {Maria Piera} and Sergio Stefoni and Magdi Yaqoob and Brennan, {Daniel C.}",
year = "2008",
month = "7",
day = "15",
doi = "10.1097/TP.0b013e31817d4df5",
language = "English",
volume = "86",
pages = "18--25",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Expanding the evidence base in transplantation

T2 - The complementary roles of randomized controlled trials and outcomes research

AU - Takemoto, Steven K.

AU - Arns, Wolfgang

AU - Bunnapradist, Suphamai

AU - Garrison, Louis P.

AU - Guirado, Lluis

AU - Kaló, Z.

AU - Oniscu, Gabriel

AU - Opelz, Gerhard

AU - Scolari, Maria Piera

AU - Stefoni, Sergio

AU - Yaqoob, Magdi

AU - Brennan, Daniel C.

PY - 2008/7/15

Y1 - 2008/7/15

N2 - Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery and collaboration necessary for the transplant procedure makes randomization and blinding difficult. Because essentially every recipient is included in a transplant registry, sampling bias is minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy of new drugs or medical interventions. This workgroup summary examines the suitability of outcomes research to complement results of randomized controlled trials and related issues: efficacy versus effectiveness, internal versus external validity, data types, limitations, and analysis methodologies. Many advances in outcomes research have been pioneered in transplantation. A case is made for regulatory and reimbursement authorities to use outcomes research when making efficacy, effectiveness, and coverage decisions in transplantation.

AB - Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery and collaboration necessary for the transplant procedure makes randomization and blinding difficult. Because essentially every recipient is included in a transplant registry, sampling bias is minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy of new drugs or medical interventions. This workgroup summary examines the suitability of outcomes research to complement results of randomized controlled trials and related issues: efficacy versus effectiveness, internal versus external validity, data types, limitations, and analysis methodologies. Many advances in outcomes research have been pioneered in transplantation. A case is made for regulatory and reimbursement authorities to use outcomes research when making efficacy, effectiveness, and coverage decisions in transplantation.

KW - Immunosuppression

KW - Outcomes research

KW - Randomized controlled trial

KW - Registry analysis

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=49849090607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49849090607&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31817d4df5

DO - 10.1097/TP.0b013e31817d4df5

M3 - Article

C2 - 18622271

AN - SCOPUS:49849090607

VL - 86

SP - 18

EP - 25

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -